3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4,6-dimethoxybenzaldehyde | 329217-86-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4,6-dimethoxybenzaldehyde
• 英文别名: 2,4-dimethoxy-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)benzaldehyde
• CAS: 329217-86-9
• 化学式: C₂₄H₃₀O₃
• 分子量: 366.5
• InChiKey: JCDWXBFYHGQVAF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.4
• 重原子数：
  27
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4,6-dimethoxybenzaldehyde 生成 3-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4,6-dimethoxybenzylidene-2,4-thiazolidinedione
  参考文献：
  名称：

  Heterocyclic derivatives for the treatment of diabetes and other diseases

  摘要：

  本发明涉及某些Formula (I)的取代杂环，这些取代杂环在治疗与脂质和碳水化合物代谢相关的疾病方面很有用，如2型糖尿病、脂肪细胞分化、不受控制的增殖，如淋巴瘤、霍奇金病、白血病、乳腺癌、前列腺癌或一般癌症；以及炎症，如骨关节炎、类风湿关节炎、克罗恩病或炎症性肠病。

  公开号：

  US06515003B1
• 作为产物：
  描述：

  3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxy-6-hydroxybenzaldehyde 、 硫酸二甲酯 在 potassium carbonate 、 sodium chloride 作用下， 以 丙酮 为溶剂， 以97%的产率得到3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4,6-dimethoxybenzaldehyde
  参考文献：
  名称：

  Heterocyclic derivatives for the treatment of diabetes and other diseases

  摘要：

  本发明涉及某些Formula (I)的取代杂环，这些取代杂环在治疗与脂质和碳水化合物代谢相关的疾病方面很有用，如2型糖尿病、脂肪细胞分化、不受控制的增殖，如淋巴瘤、霍奇金病、白血病、乳腺癌、前列腺癌或一般癌症；以及炎症，如骨关节炎、类风湿关节炎、克罗恩病或炎症性肠病。

  公开号：

  US06515003B1

文献信息

• Substituted heterocycles for the treatment of diabetes and other diseases
  申请人：Pfahl Magnus

  公开号：US20060004059A1

  公开（公告）日：2006-01-05

  The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease.

  本发明涉及公式（I）的某些取代杂环，其在治疗与脂质和碳水化合物代谢有关的疾病中有用，例如2型糖尿病，脂肪细胞分化，不受控制的增殖（如淋巴瘤，霍奇金病，白血病，乳腺癌，前列腺癌或癌症总体）和炎症（如骨关节炎，类风湿性关节炎，克罗恩病或炎性肠病）。
• Imidazolidinedione derivatives for the treatment of diabetes and other diseases
  申请人：Pfahl Magnus

  公开号：US20050070581A1

  公开（公告）日：2005-03-31

  The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease.

  本发明涉及某些式(I)的取代杂环，其在治疗与脂质和碳水化合物代谢有关的疾病方面是有用的，例如2型糖尿病、脂肪细胞分化、不受控制的增殖，如淋巴瘤、霍奇金病、白血病、乳腺癌、前列腺癌或普遍的癌症；以及炎症，例如骨关节炎、类风湿性关节炎、克罗恩病或炎性肠病。
• Thiazolidinedione derivatives for the treatment of diabetes and other diseases
  申请人：Maxia Pharmaceuticals, Inc.

  公开号：US20030153606A1

  公开（公告）日：2003-08-14

  The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease. 1

  本发明涉及公式(I)的某些取代杂环，其在治疗与脂质和碳水化合物代谢相关的疾病方面有用，例如2型糖尿病、脂肪细胞分化、不受控制的增殖，例如淋巴瘤、霍奇金病、白血病、乳腺癌、前列腺癌或一般的癌症；以及炎症，例如骨关节炎、风湿性关节炎、克隆氏病或炎性肠病。
• Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
  申请人：Incyte San Diego Incorporated

  公开号：EP1593677A2

  公开（公告）日：2005-11-09

  The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatiod arthritis, Crohn's Disease or Inflammatory Bowel Disease.

  本发明涉及某些取代的式(I)杂环，可用于治疗与脂质和碳水化合物代谢有关的疾病，如 2 型糖尿病、脂肪细胞分化、增殖失控，如淋巴瘤、霍奇金病、白血病、乳腺癌、前列腺癌或一般癌症；以及炎症，如骨关节炎、风湿性关节炎、克罗恩病或炎症性肠病。
• BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF DIABETES
  申请人：Maxia Pharmaceuticals, Inc.

  公开号：EP1214304A1

  公开（公告）日：2002-06-19